Combination of Zizyphus jujuba and green tea extracts exerts excellent cytotoxic activity in HepG2 cells via reducing the expression of APRIL

American Journal of Chinese Medicine

Volumn 37, Issue 1, 2009, Pages 169-179

  Huang, Xuedan ^a   Kojima Yuasa, Akiko ^a   Xu, Shenghui ^a   Kennedy, David Opare ^a   Hasuma, Tadayoshi ^b   Matsui Yuasa, Isao ^a  

^a Osaka City University   (Japan)

^b International Buddhist University   (Japan)

Author keywords

APRIL; GTE; p21Waf1 Cip1; p27Kip1; p53; Zizyphus jujuba Mill

Indexed keywords

APRIL PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GREEN TEA EXTRACT; JUJUBE EXTRACT; PROTEIN P53;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CELL ISOLATION; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIVER CELL; LIVER CELL CARCINOMA; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 65449167583     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X09006758     Document Type: Article

References (29)

1. Abou-Alfa, G.K. Hepatocellular carcinoma: Molecular biology and therapy. Semin. Oncol. 33: S79-83, 2006.
2. Arimura, T., A. Kojima-Yuasa, M. Suzuki, D.O. Kennedy and I. Matsui-Yuasa. Caspase-independent apoptosis induced by evening primrose extract in Ehrlich ascites tumor cells. Cancer Lett. 201: 9-16, 2003a.
3. Arimura, T., A. Kojima-Yuasa, S. Watanabe, M. Suzuki, D.O. Kennedy and I. Matsui-Yuasa. Role of intracellular reactive oxygen species and mitochondrial dysfunction in evening primrose extract-induced apoptosis in Ehrlich ascites tumor cells. Chem. Biol. Interact. 145: 337-347, 2003b.
4. Guan, Y.S. and Y. Liu. Interventional treatments for hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. 5: 495-500, 2006.
5. Hahne, M., T. Kataoka, M. Schroter, K. Hofmann, M. Irmler, J.L. Bodmer, P. Schneider, T. Bornand, N. Holler, L.E. French, B. Sordat, D. Rimoldi and J. Tschopp. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188: 1185-1190, 1998.
6. Haiat, S., C. Billard, C. Quiney, F. Ajchenbaum-Cymbalista and J.P. Kolb. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology 118: 281-292, 2006.
7. Harper, J.W., S.J. Elledge, K. Keyomarsi, B. Dynlacht, L.H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell and et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6: 387-400, 1995.
8. Hernandez-Alcoceba, R., B. Sangro and J. Prieto. Gene therapy of liver cancer. World J. Gastroenterol. 12: 6085-6097, 2006.
9. Hirai, H., M.F. Roussel, J.Y. Kato, R.A. Ashmun and C.J. Sherr. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell Biol. 15: 2672-2681, 1995.
10. Huang, X., A. Kojima-Yuasa, T. Norikura, D.O. Kennedy, T. Hasuma and I. Matsui-Yuasa. Green tea extract enhances the selective cytotoxic activity of Zizyphus jujuba extracts in HepG2 cells. Am. J. Chin. Med. 36: 729-744, 2008.
11. Huang, X., A. Kojima-Yuasa, T. Norikura, D.O. Kennedy, T. Hasuma and I. Matsui-Yuasa. Mechanism of the anti-cancer activity of Zizyphus jujuba in HepG2 cells. Am. J. Chin. Med. 35: 517-532, 2007.
12. Kametani, S., A. Kojima-Yuasa, H. Kikuzaki, D.O. Kennedy, M. Honzawa and I. Matsui-Yuasa. Chemical constituents of cape aloe and their synergistic growth-inhibiting effect on Ehrlich ascites tumor cells. Biosci. Biotechnol. Biochem. 71: 1220-1229, 2007a.
13. Kametani, S., T. Oikawa, A. Kojima-Yuasa, D.O. Kennedy, T. Norikura, M. Honzawa and I. Matsui-Yuasa. Mechanism of growth inhibitory effect of cape aloe extract in ehrlich ascites tumor cells. J. Nutr. Sci. Vitaminol. (Tokyo) 53: 540-546, 2007b.
14. Kelly, K., E. Manos, G. Jensen, L. Nadauld and D.A. Jones. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 60: 1021-1027, 2000.
15. Kennedy, D.O., A. Kojima, J. Moffatt, H. Yamagiwa, Y. Yano, T. Hasuma, S. Otani and I. Matsui-Yuasa. Cellular thiol status-dependent inhibition of tumor cell growth via modulation of retinoblastoma protein phosphorylation by (-)-epigallocatechin. Cancer Lett. 179: 25-32, 2002.
16. Lau, W. Future perspectives for hepatocellular carcinoma. HPB. (Oxford) 5: 206-213, 2003.
17. Levrero, M. Viral hepatitis and liver cancer: The case of hepatitis C. Oncogene 25: 3834-3847, 2006.
18. Lopez, P.M., A. Villanueva, S. Roayaie and J.M. Llovet. Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: A critical appraisal. Liver Transpl. 12: 1747-1754, 2006.
19. Midorikawa, Y., M. Makuuchi, W. Tang and H. Aburatani. Microarray-based analysis for hepatocellular carcinoma: Fromgene expression profiling to new challenges. World J. Gastroenterol. 13: 1487-1492, 2007.
20. Newman, D.J., G.M. Cragg and K.M. Snader. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 66: 1022-1037, 2003.
21. Nishio, M., T. Endo, N. Tsukada, J. Ohata, S. Kitada, J.C. Reed, N.J. Zvaifler and T.J. Kipps. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106: 1012-1020, 2005.
22. Okano, H., K. Shiraki, Y. Yamanaka, H. Inoue, T. Kawakita, Y. Saitou, Y. Yamaguchi, N. Enokimura, K. Ito, N. Yamamoto, K. Sugimoto, K. Murata and T. Nakano. Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization. World J. Gastroenterol. 11: 4650-4654, 2005.
23. Perry, M.E. and A.J. Levine. Tumor-suppressor p53 and the cell cycle. Curr. Opin. Genet. Dev. 3: 50-54, 1993.
24. Rennert, P., P. Schneider, T.G. Cachero, J. Thompson, L. Trabach, S. Hertig, N. Holler, F. Qian, C. Mullen, K. Strauch, J.L. Browning, C. Ambrose and J. Tschopp. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J. Exp. Med. 192: 1677-1684, 2000.
25. Riddell, R.J., R.H. Clothier and M. Balls. An evaluation of three in vitro cytotoxicity assays. Food Chem. Toxicol. 24: 469-471, 1986.
26. Roninson, I.B. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/ Sdi1): Association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 179: 1-14, 2002.
27. Schnier, J.B., K. Nishi, D.W. Goodrich and E.M. Bradbury. G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637. Proc. Natl. Acad. Sci. USA 93: 5941-5946, 1996.
28. Wang, H.K. The therapeutic potential of flavonoids. Expert. Opin. Investig. Drugs 9: 2103-2119, 2000.
29. Ware, C.F. APRIL and BAFF connect autoimmunity and cancer. J. Exp. Med. 192: F35-38, 2000.